Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market.
Following the successful development and production of the Cellbox transportable CO2 incubator in 2019, as well as suitable UN3373 packaging materials for cell transport, the young company has decided to expand into the USA. The high amount of enquiries from the US market made it obvious to take the next step and expand to the USA. The market was previously served by a distribution partner, but effective immediately, the products will be sold directly through Cellbox Solutions Inc. based in Rockville, Maryland.
Wolfgang Kintzel, CEO of Cellbox Solutions GmbH, has already established several life science start-ups in the American market and is proud of the rapid development of the young company: “We are pursuing a clear expansion strategy with the aim of becoming the global market leader in the field of cell logistics. Expanding into the U.S. market, which is a leader in cell and gene therapy, was therefore the next logical step. With Stephanie Dennison, we are pleased to be able to establish the first team member permanently on site and be the direct contact for prospective customers requiring Live Cell Shipping.”
Stephanie Dennison joined the team in July 2021 as the Business Development Manager on the East Coast. Stephanie has a master’s degree in molecular biology from the University of Maryland Baltimore County, as well as several years of sales experience at e.g. ChromoTek Inc. before joining Cellbox Solutions Inc.
Dr. Corné Swart, Executive Director Business Development and Global Sales, adds: “We want to make the sales process as straightforward as possible for our customers. A highly innovative product like the Cellbox still requires intensive consulting services in some cases, so it is a great advantage for everyone that we are now even closer to our prospects.”
